[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100439002":3},{"organization":4,"armGroups":7,"interventions":16,"overallOfficials":36,"centralContacts":40,"locations":49,"responsibleParty":102,"collaborators":105,"id":109,"slug":110,"hasResults":111,"nctId":112,"briefTitle":113,"officialTitle":113,"acronym":114,"eligibilityCriteria":115,"healthyVolunteers":111,"sex":116,"minAge":117,"maxAge":44,"enrollmentInfo":118,"targetDuration":44,"studyType":121,"phases":122,"briefSummary":124,"conditions":125,"keywords":128,"overallStatus":52,"whyStopped":44,"lastUpdateSubmitDate":133,"lastUpdatePostDateStruct":134,"startDateStruct":137,"completionDateStruct":139,"leadSponsor":141,"locationsCount":142},{"fullName":5,"class":6},"University of Pittsburgh","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Pancreatic Quantitative Sensory Testing (P-QST)","EXPERIMENTAL","Definite Chronic Pancreatitis patients undergoing decompressive invasive treatments (endoscopic therapy or surgery) to relieve main pancreatic duct obstruction due to stones and\u002For stricture for management of pain will undergo P-QST prior to clinically-indicated invasive treatment.",[13,14,15],"Diagnostic Test: Quantitative Sensory Test 1","Diagnostic Test: Quantitative Sensory Test 2","Diagnostic Test: Quantitative Sensory Test 3",[17,24,30],{"type":18,"name":19,"description":20,"armGroupLabels":21,"otherNames":22},"DIAGNOSTIC_TEST","Quantitative Sensory Test 1","Subject will give pain rating (on Visual Analogue Scale (VAS) 0-10) of single as well as multiple stimulation with round-tip non-invasive pin-prick device. Difference is recorded as Temporal Summation Score.",[9],[23],"Temporal Summation",{"type":18,"name":25,"description":26,"armGroupLabels":27,"otherNames":28},"Quantitative Sensory Test 2","Subject will state when they first detect pain and pain detection threshold in response to pressure administration with pressure algometer. Pressure threshold recorded in kilopascals(kP). Stimulation will be repeated in pancreatic and control dermatomes. Subject will then state pain tolerance threshold at same locations. Sensitization will be characterized by ratio of pancreatic vs. control dermatome scores.",[9],[29],"Pressure Threshold Testing",{"type":18,"name":31,"description":32,"armGroupLabels":33,"otherNames":34},"Quantitative Sensory Test 3","Subject will apply dominant hand to ice-chilled water bath (36F) for up to 2 minutes. Pain score (VAS 0-10) will be assessed each 10 seconds. Pain tolerance threshold (in kP) will be assessed with algometer on non-dominant thigh before and after water bath to determine change in threshold. Difference in pain tolerance recorded as Conditioned Pain Modulation Score.",[9],[35],"Conditioned Pain Modulation",[37],{"name":38,"affiliation":5,"role":39},"Anna Evans Phillips, MD, MS","PRINCIPAL_INVESTIGATOR",[41,46],{"name":38,"role":42,"phone":43,"phoneExt":44,"email":45},"CONTACT","412-647-2345",null,"evansac3@upmc.edu",{"name":47,"role":42,"phone":44,"phoneExt":44,"email":48},"Apsara Mishra","apm179@pitt.edu",[50,71,88],{"facility":51,"status":52,"city":53,"state":54,"zip":55,"country":56,"countryCode":57,"cosmosGeoPoint":58,"geoPoint":63,"contacts":64},"Indiana University Medical Center","RECRUITING","Indianapolis","Indiana","46202","United States","US",{"type":59,"coordinates":60},"Point",[61,62],-86.15804,39.76838,{"lat":62,"lon":61},[65,69],{"name":66,"role":42,"phone":67,"phoneExt":44,"email":68},"Suzette Schmidt, RN","317-278-0691","suschmid@iu.edu",{"name":70,"role":39,"phone":44,"phoneExt":44,"email":44},"Jeffrey Easler, MD",{"facility":72,"status":52,"city":73,"state":74,"zip":75,"country":56,"countryCode":57,"cosmosGeoPoint":76,"geoPoint":80,"contacts":81},"Johns Hopkins Medical Institutions","Baltimore","Maryland","21287",{"type":59,"coordinates":77},[78,79],-76.61219,39.29038,{"lat":79,"lon":78},[82,86],{"name":83,"role":42,"phone":84,"phoneExt":44,"email":85},"Mahya Faghih, MD","410-614-6708","mfaghih2@jhu.edu",{"name":87,"role":39,"phone":44,"phoneExt":44,"email":44},"(Site) Vikesh K Singh, MD, MSc",{"facility":89,"status":52,"city":90,"state":91,"zip":92,"country":56,"countryCode":57,"cosmosGeoPoint":93,"geoPoint":97,"contacts":98},"University of Pittsburgh Medical Center","Pittsburgh","Pennsylvania","15213",{"type":59,"coordinates":94},[95,96],-79.99589,40.44062,{"lat":96,"lon":95},[99,101],{"name":100,"role":42,"phone":43,"phoneExt":44,"email":45},"Anna E Phillips, MD, MS",{"name":100,"role":39,"phone":44,"phoneExt":44,"email":44},{"type":39,"investigatorFullName":103,"investigatorTitle":104,"investigatorAffiliation":5,"oldNameTitle":44,"oldOrganization":44},"Anna Evans Phillips","Principal Investigator",[106],{"name":107,"class":108},"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","NIH","100439002","pancreatic-quantitative-sensory-testing-p-qst-to-predict-treatment-response-for-pain-in-chronic-pancreatitis-100439002",false,"NCT04996628","Pancreatic Quantitative Sensory Testing (P-QST) to Predict Treatment Response for Pain in Chronic Pancreatitis","P-QST","Inclusion Criteria:\n\n* Adult patients ≥ 18 years of age with definite CP undergoing decompressive invasive treatments (endoscopic therapy or surgery) to relieve main pancreatic duct obstruction due to stones and\u002For stricture for management of pain.\n\n  * Endoscopic therapy: Endoscopic Retrograde Cholangiopancreatography (ERCP) with pancreatic duct stone removal, stent placement, and\u002For stricture dilation, ± intraductal lithotripsy or Extracorporeal Shock Wave Lithotripsy (ESWL).\n  * Surgery: drainage procedures (Frey and Puestow operations)\n\nExclusion Criteria:\n\n* Patients with chronic pain from conditions other than CP\n* Patients \\\u003C 18 years of age\n* Patients who have had endoscopic therapy within the past 12 months\n* Patients who have undergone prior pancreatic surgery\n* Patients who have resective surgical procedure planned (eg. Whipple procedure, Total Pancreatectomy)\n* Patients with peripheral sensory deficits\n* Patients with known pregnancy at the time of study screening\\*\\*\n\n  * Note: Women who become pregnant during the course of the study can no longer participate in P-QST testing.","ALL","18 Years",{"count":119,"type":120},150,"ESTIMATED","INTERVENTIONAL",[123],"NA","Abdominal pain in chronic pancreatitis (CP) affects up to 90% of patients during the course of their disease, and response to currently available therapies is suboptimal and unpredictable. The proposed clinical trial will evaluate the predictive capability of Pancreatic Quantitative Sensory Testing (P-QST) - a novel assessment of neurosensory phenotyping- for improvement in pain in patients with CP who are undergoing medically-indicated invasive treatment with endoscopic therapy or surgery.",[126,127],"Chronic Pancreatitis","Chronic Pain",[127,126,129,130,131,132],"Recurrent Acute Pancreatitis","Chronic Abdominal Pain","ERCP","Pancreatic Surgery","2025-12-19",{"date":135,"type":136},"2025-12-22","ACTUAL",{"date":138,"type":136},"2022-01-04",{"date":140,"type":120},"2026-06-30",{"name":5,"class":6},3]